Found: 2
Select item for more details and to access through your institution.
P14.13 Severe hematological toxicity during chemoradiation for glioblastoma: Identification of clinical and pharmacological risk factors and consequences for the individual patient.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii40, doi. 10.1093/neuonc/noab180.138
- By:
- Publication type:
- Article
OS05.7.A Absence of severe hematological toxicity during first line treatment predicts low chance on severe toxicity during second line alkylating chemotherapy in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii8, doi. 10.1093/neuonc/noab180.023
- By:
- Publication type:
- Article